Study finds many psychiatric disorders have heightened impulsivity

Individuals with many different psychiatric disorders have a higher tendency to choose smaller, immediate rewards over larger, delayed rewards, a study led by Hamilton researchers has found.

By Mike Beattie, The Research Institute of St. Joe's Hamilton August 28, 2019

Michael Amlung (left) and Randi McCabe are McMaster researchers who led a study showing impulsivity goes hand-in-hand with many psychiatric disorders.

Experts Featured In This Story

Michael Amlung
Michael Amlung

Associate Professor (Part-Time)

See Profile
Randi McCabe
Randi McCabe

Professor

See Profile

Individuals with many different psychiatric disorders have a higher tendency to choose smaller, immediate rewards over larger, delayed rewards, a study led by Hamilton researchers has found.

The findings of a meta-analysis by researchers of McMaster University and St. Joseph’s Healthcare Hamilton, which combined data from more than 40 studies, was published in JAMA Psychiatry today.

That this type of decision-making tied to impulsivity, called delay discounting, is heightened in those with certain psychiatric disorders compared to others, is expected to have an important impact on future research and treatment across an array of disorders.

“The revelation that delay discounting is one of these ‘trans-diagnostic’ processes will have a significant effect on the future of psychiatric diagnosis and treatment,” said Michael Amlung, lead author of the study.

Amlung is an assistant professor of psychiatry and behavioural neurosciences at McMaster University and researcher for the Peter Boris Centre for Addictions Research at St. Joseph’s Healthcare Hamilton.

The study analyzed data from studies across eight different psychiatric disorders, including major depressive disorder, bipolar disorder, borderline personality disorder, schizophrenia, eating disorders, and others. The largest delay discounting effects were found to be associated with bipolar disorder, borderline personality disorder, and schizophrenia.

Previous research has linked a greater preference for immediate rewards and impulsivity to negative health outcomes, such as addiction, obesity, and ADHD. This study reinforced that negative association, finding that impulsive preferences are consistently observed across an even broader range of psychiatric disorders.

Interestingly, the study also found the opposite pattern in those with anorexia nervosa. The researchers explained that the greater preference for delayed over immediate rewards seen in people with anorexia is consistent with excessive self-control of their eating habits.

The study authors say this pattern suggests that delay discounting preferences are best thought of as being on a continuum, with some disorders exhibiting excessively impulsive decisions and other disorders exhibiting excessively self-controlled decisions.

“Examining factors that cut across psychiatric disorders, such as delay discounting, helps to illuminate commonalities and distinguishing characteristics amongst disorders that then guide further research on treatment and prevention,” said Randi McCabe, co-author of the paper, psychologist-in-chief at St. Joseph’s Healthcare Hamilton and professor of psychiatry and behavioural neurosciences at McMaster.

“The more we understand the nature of psychiatric illness, the better we are equipped to provide effective treatment strategies,” she said.

The authors say the study findings support the inclusion of delay discounting in the Research Domain Criteria (RDoC) framework proposed by the National Institute of Mental Health, as a potent indicator of psychiatric illness. RDoC is a biologically-valid framework for understanding mental disorders, and includes research approaches in genetics, neuroscience, and behavioural science.

“Our results provide strong evidence for delay discounting as a core behavioural process within the RDoC framework,” Amlung said. “On a broader level, this study underscores the need for future research examining common neurobiological and genetic underpinnings of this type of decision making in order to inform evidence-based treatments across psychiatric disorders.”

The Peter Boris Centre for Addictions Research, a partnership of St. Joseph’s Healthcare Hamilton and McMaster University, partially funded this study.

Marek Smieja smiles while standing outside on a bright day.

McMaster scientist Marek Smieja receives prestigious national award for infectious disease research 

The John G. FitzGerald Award recognizes Smieja for advancing the diagnosis and epidemiology of respiratory and gastrointestinal infections, including those caused by SARS-CoV-2, influenza, rhinovirus, and C. difficile.
Toronto skyline enveloped in yellowish smog.

Everyday air pollution linked to poorer brain function, study finds

New research suggests that fine particles from traffic, industry and wildfire smoke are linked to worse cognitive function.
Smiling Sheila Singh wearing a McMaster lab coat, looking over lab equipment.

New McMaster-made drug candidate shows promise as a brain cancer treatment 

The drug candidate can eliminate deadly and aggressive glioblastoma tumours, which typically resist standard treatments and often recur rapidly.